Author name: enrightpr

Fanatics

Fanatics Expands in India: New VP, Larger Office, 500+ Team by 2026

Newsroom /

Hyderabad, February 28, 2025 –Fanatics, a leading global digital sports platform with 22,000 employees across more than 80 locations, has announced strengthening of its leadership, increasing in technical hiring, and expanding its footprint within India.Fanatics continues to grow and scale its business with technology, data, and the application of AI to drive the company’s success. […]

Fanatics Expands in India: New VP, Larger Office, 500+ Team by 2026 Read More »

Biovet DIVA LSD Vaccine

CDSCO Approves Biovet’s Safe, Effective DIVA LSD Vaccine for Dairy Cattle

Newsroom /

Mallur, Karnataka, February 11 2025 — In a groundbreaking development for the animal health sector, Biovet, a leading innovator in animal vaccines and a part of the Bharat Biotech Group, has announced that its world-first Differentiating Infected from Vaccinated Animals (DIVA) marker vaccine for Lumpy Skin Disease (LSD) has been granted approval by the Central

CDSCO Approves Biovet’s Safe, Effective DIVA LSD Vaccine for Dairy Cattle Read More »

AM Green DP World Pact for Green Fuels Export

AM Green, DP World Pact to Export 2MPTA Green Fuels

Newsroom /

Hyderabad, India, January 15, 2025: AM Green, a leader in green hydrogen and ammonia production, has partnered with DP World, a global logistics leader, to create a sustainable supply chain for green fuels and chemicals. This collaboration will significantly enhance global decarbonisation efforts by enabling seamless exports to key consumption markets. Under the Memorandum of

AM Green, DP World Pact to Export 2MPTA Green Fuels Read More »

HILLCHOL by Bharat Biotech

New Oral Cholera Vaccine ‘HILLCHOL’ by Bharat Biotech Tackles Global Deficit

Newsroom /

August 28, 2024: Bharat Biotech International Limited (BBIL) announced the launch of HILLCHOL® (BBV131), a novel single-strain Oral Cholera Vaccine (OCV). The OCV was developed by Bharat Biotech under license from Hilleman Laboratories (funded by Merck, USA and Wellcome Trust, UK), to combat cholera, a significant advancement in global health. Currently, only one manufacturer supplies

New Oral Cholera Vaccine ‘HILLCHOL’ by Bharat Biotech Tackles Global Deficit Read More »

AM Green

AM Green Achieves FID for First 1Mn Ton Green Ammonia Project

Newsroom /

August 28, 2024: AM Green Ammonia B.V. (“Company”) has achieved Final Investment Decision (FID) for its first million-ton green ammonia project located in Kakinada, Andhra Pradesh, India. FID for this project kick starts the Company’s target production capacity of 5 million tons per annum (MTPA) of green ammonia by 2030 – equivalent to about 1

AM Green Achieves FID for First 1Mn Ton Green Ammonia Project Read More »

HYLENR

HYLENR Breakthrough Low Energy Nuclear Reactor Receives Patent

Newsroom /

July 18, 2024: Hyderabad based Startup HYLENR’s has demonstrated world’s first and a ground breaking cold fusion technology to generate Clean Energy. This innovation has received a patent from the Government of India for its Low Energy Nuclear Reactor Technology. HYLENR’s Low Energy Nuclear Reactor is a promising alternative for power generation, by amplifying input

HYLENR Breakthrough Low Energy Nuclear Reactor Receives Patent Read More »

PR and Brand Communications

Don’t Automate Your Reputation: The Human Edge in PR

Newsroom /

July 13, 2024: Generative AI is taking the world by storm, and the realm of PR and brand communications isn’t exempt. While AI offers exciting possibilities for content creation and data analysis, it’s crucial to recognize its limitations before handing over the reins of your brand image. Here’s why human expertise remains irreplaceable in building

Don’t Automate Your Reputation: The Human Edge in PR Read More »